Sacchi MC, Tamiazzo S, Stobbione P, et al. SARS-CoV-2
infection as a trigger of autoimmune response. Clin Transl Sci.
2021;14(3):898–907....
Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical
course of rheumatic manifestations. Clin Rheumatol. 2021;40(7):
2611–2619. https://doi.org/10.1007/s10067-021-05691-x.
Alessandro C, Nazareno G, Georgios BC, et al. Morphea
(Localized Scleroderma) in a COVID-19 patient: a case report. J
Clin Immunol Microbiol...
De Medeiros VLS, Monteiro-Neto AU, França DDT, et al.
Pemphigus Vulgaris after COVID-19: a case of induced
autoimmunity. SN Compr Clin Med....
Ozaras R, Berk A, Ucar DH, et al. Covid-19 and exacerbation of
psoriasis. Dermatol Ther. 2020;33(4):1–2. https://doi.org/10.1111/
dth.13632.
González González FE, Muñoz Angulo N, Cortés Correa CI,
et al. Exacerbación de psoriasis secundaria a infección por
SARS-CoV-2. Piel. 2022....
Paces J, Strizova Z, Smrz D, et al. COVID-19 and the immune
system. Physiol Res. 2020:379–388. https://doi.org/10.33549/
physiolres.934492...
González González F, Cortés Correa C, Peñaranda Contreras E.
Manifestaciones cutáneas en pacientes con COVID-19:
características clínicas...
Varga J, Denton CP, Wigley FM. Scleroderma: From Pathogenesis to Comprehensive Management. New York: Springer
International Publishing; 2017....
Egami S, Yamagami J, Amagai M. Autoimmune bullous skin
diseases, pemphigus and pemphigoid. J Allergy Clin Immunol.
2020;145(4):1031–1047....
